Tin tức & Cập nhật

Continued anti-VEGF use after disease control does not prevent nAMD recurrence
Continued anti-VEGF use after disease control does not prevent nAMD recurrence
06 Apr 2022

In patients with neovascular age-related macular degeneration (nAMD) who achieve functional and morphological disease stability, continuing treatment with antivascular endothelial growth factors (anti-VEGF) does not substantially reduce the risk of recurrence, reports a recent study.

Continued anti-VEGF use after disease control does not prevent nAMD recurrence
06 Apr 2022
Insulin pump, CGM use linked to better glucose control during pregnancy
Insulin pump, CGM use linked to better glucose control during pregnancy
06 Apr 2022